Archive for October, 2010



A problem with pills

Sunday 31 October 2010 @ 6:43 am

The number of prescription pill trafficking and possession cases is on the rise in Marion County, prosecutors say.




HL:Medicine Hat Tigers edge Chilliwack Bruins 5-4 behind Etem’s hat trick@

Sunday 31 October 2010 @ 2:00 am

MEDICINE HAT, Alta. <emdash /> In a contest that had a very intense feel to it, the Medicine Hat Tigers slipped past the Chilliwack Bruins …




A problem with pills

Sunday 31 October 2010 @ 12:59 am

The number of prescription pill trafficking and possession cases is on the rise in Marion County, prosecutors say




Why drug companies might be paying your doctor to tout their products

Saturday 30 October 2010 @ 4:15 pm

York, PA - A recent report by public interest research website ProPublica says it’s common for drug companies to pay doctors for lecturing about their products. It’s legal, but, the report says, raises ethical questions. (Search to see if your doctor is on the list).




Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval For Treatment Of Peripheral Neuropathic Pain In Japan

Saturday 30 October 2010 @ 7:15 am

Pfizer Inc.(NYSE: PFE) announced today that the Japanese Ministry of Health, Labour and Welfare approved Lyrica® (pregabalin) capsules for the treatment of peripheral neuropathic pain. This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010. Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co …




PUMA’s Project Pink program raises funds for Women’s Cancer Research Center

Saturday 30 October 2010 @ 1:45 am

PUMA is excited to announce the results of the sportlifestyle brand’s Project Pink program, developed in conjunction with PUMA’s partnership with the dynamic female athletes of Women’s Professional Soccer.




FDA approves NUEDEXTA capsules for pseudobulbar affect

Saturday 30 October 2010 @ 1:15 am

AVANIR Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect.




FDA approves NUEDEXTA capsules for pseudobulbar affect

Saturday 30 October 2010 @ 1:15 am

AVANIR Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate) capsules, as the first treatment for pseudobulbar affect.




Health Tip: Prevent Rebound Headaches

Saturday 30 October 2010 @ 12:26 am

Title: Health Tip: Prevent Rebound Headaches Category: Health News Created: 10/29/2010 12:05:00 PM Last Editorial Review: 10/29/2010




KCTV5 Investigation: A Coroner’s Alert

Friday 29 October 2010 @ 11:42 pm

In a KCTV5 investigation, an area coroner is issuing an alert to people about the dangers associated with the use of the Fentanyl patch.




«« Previous Posts